Potassium orotate, tablets 500 mg 20 pcs

Pharmacotherapeutic group: metabolic agent. ATX code: A05BA The drug is potassium salt of orotic acid. Orotic acid is one of the precursors of pyrimidine nucleotides that are part of nucleic acids involved in the synthesis of protein molecules, so orotic acid salts are considered as substances of anabolic action and are used in disorders of protein metabolism for their stimulation.

Potassium orotate stimulates the synthesis of nucleic acids, albumin production in the liver, especially in conditions of prolonged hypoxia (oxygen deficiency), increases appetite, has diuretic (diuretic) and regenerating properties.

Pharmacokinetics
After oral administration 10 % of the ingested dose is absorbed in gastrointestinal tract. It is converted into orotidine-5-phosphate in the liver. It is excreted by the kidneys (30% as metabolites).

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Attention to diet is advisable during treatment.

Ability to affect reaction time while driving or operating other machinery
The drug does not cause drowsiness and decrease psychomotor reaction speed.

The drug does not cause drowsiness and decrease psychomotor reaction speed.

Synopsis

Contraindications

Side effects

Overdose